Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy

Author:

Schindl M1ORCID,Függer R2,Götzinger P3,Längle F4,Zitt M56,Stättner S57,Kornprat P8,Sahora K1,Hlauschek D9,Gnant M1

Affiliation:

1. Department of Surgery, Medical University of Vienna – General Hospital, Vienna, Austria

2. Department of Surgery, Hospital Elisabethinen, Linz, Austria

3. Department of Surgery, University Hospital St Pölten, St Pölten, Austria

4. Department of Surgery, State Hospital Wiener Neustadt, Wiener Neustadt, Austria

5. Department of Surgery, Medical University of Innsbruck, Innsbruck, Austria

6. Department of Surgery, District Hospital Dornbirn, Dornbirn, Austria

7. Department of Surgery, Medical University of Salzburg, Salzburg, Austria

8. Department of Surgery, Medical University of Graz, Graz, Austria

9. Department of Statistics, Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria

Abstract

Abstract Background The potential for a fibrin sealant patch to reduce the risk of postoperative pancreatic fistula (POPF) remains uncertain. The aim of this study was to evaluate whether a fibrin sealant patch is able to reduce POPF in patients undergoing pancreatoduodenectomy with pancreatojejunostomy. Methods In this multicentre trial, patients undergoing pancreatoduodenectomy were randomized to receive either a fibrin patch (patch group) or no patch (control group), and stratified by gland texture, pancreatic duct size and neoadjuvant treatment. The primary endpoint was POPF. Secondary endpoints included complications, drain-related factors and duration of hospital stay. Risk factors for POPF were identified by logistic regression analysis. Results A total of 142 patients were enrolled. Forty-five of 71 patients (63 per cent) in the patch group and 40 of 71 (56 per cent) in the control group developed biochemical leakage or POPF (P = 0·392). Fistulas were classified as grade B or C in 16 (23 per cent) and ten (14 per cent) patients respectively (P = 0·277). There were no differences in postoperative complications (54 patients in patch group and 50 in control group; P = 0·839), drain amylase concentration (P = 0·494), time until drain removal (mean(s.d.) 11·6(1·0) versus 13·3(1·3) days; P = 0·613), fistula closure (17·6(2·2) versus 16·5(2·1) days; P = 0·740) and duration of hospital stay (22·1(2·2) versus 18·2(0·9) days; P = 0·810) between the two groups. Multivariable logistic regression analysis confirmed that obesity (odds ratio (OR) 5·28, 95 per cent c.i. 1·20 to 23·18; P = 0·027), soft gland texture (OR 9·86, 3·41 to 28·54; P < 0·001) and a small duct (OR 5·50, 1·84 to 16·44; P = 0·002) were significant risk factors for POPF. A patch did not reduce the incidence of POPF in patients at higher risk. Conclusion The use of a fibrin sealant patch did not reduce the occurrence of POPF and complications after pancreatoduodenectomy with pancreatojejunostomy. Registration number: 2013-000639-29 (EudraCT register).

Funder

Takeda Pharmaceutical Company

Publisher

Oxford University Press (OUP)

Subject

Surgery

Reference41 articles.

1. International Study Group on Pancreatic Surgery (ISGPS). The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after;Bassi;Surgery,2017

2. Clinical implications of the 2016 International Study Group on Pancreatic Surgery definition and grading of postoperative pancreatic fistula on 775 consecutive pancreatic resections;Pulvirenti;Ann Surg,2017

3. Characterization and optimal management of high-risk pancreatic anastomoses during pancreatoduodenectomy;Ecker;Ann Surg,2017

4. Prophylactic octreotide for pancreatoduodenectomy: more harm than good?;McMillan;HPB (Oxford),2014

5. Pancreatic anastomosis after pancreatoduodenectomy: a position statement by the International Study Group of Pancreatic Surgery (ISGPS);Shrikhande;Surgery,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3